YAP1 and osteosarcoma: VP also inhibited the proliferation of osteosarcoma (U-2OS) and mesothelioma (211H, H2052) cell lines by targeting YAP and its target genes, which upregulated N-cadherin and β-catenin (Zhang et al., 2017; Zucchini et al., 2019).